Invest with Purpose

Essential News

Biomerics Announces Expansion in Costa Rica with New Plant in Cartago

Biomerics Announces Expansion in Costa Rica with New Plant in Cartago

Cartago, Costa Rica. Monday, January 24, 2022. Biomerics, a leading medical device contract manufacturer for the interventional device market, inaugurated its second plant in Costa Rica.  The plant will be dedicated to medical device solutions for extrusion, injection molding, micromachining metals processing, and final assembly processes in cleanrooms. The new facility –adjacent to the first, in the Zeta Free Trade Zone in Cartago– represents a significant growth for Biomerics manufacturing operations in Costa Rica.

The construction and equipping of the facility required an investment of $9.5 million and covers an area of 11,000 square meters, allowing for a full-service, vertically integrated business model. The company already employs 400 people in its current facilities and, with this new plant, Biomerics will hire about 250 new employees in 2022, and expects to reach 1000 employees by 2024.

The new facility in Cartago features engineering and quality inspection laboratories, controlled manufacturing spaces, offices, ISO class 8 cleanrooms, and  packaging and warehousing spaces.

"This expansion is a recognition of the great work of the Costa Rica team”, said Travis Sessions, CEO of Biomerics. “Our global customers demand a vertically integrated operation that provides world-class quality, scale and global distribution. Costa Rica is the ideal location to deliver these customer needs”.

"Our staff has demonstrated that investing in this country is investing in proven human talent," stated Anthony Amador, President of Biomerics Costa Rica. "The satisfaction of our customers drives us to continue working. This team's commitment reaffirms Biomerics' confidence in Costa Rica to establish itself, put down roots and continue creating solutions that leave a mark in the world of medicine".

The President of the Republic, Carlos Alvarado Quesada, stated that this expansion reaffirms that the country is a reliable partner for companies, because of the legal security it offers, the good business climate and the high quality human talent, which is recognized internationally.

He also thanked the company for ratifying its confidence with a new facility, which will generate 250 jobs by 2022.

Andrés Valenciano, Minister of Foreign Trade, commented, "We are pleased to start the year with the news of Biomerics' expansion, which consolidates Costa Rica's strong position in the development of business in the medical device industry. These new facilities will house manufacturing procedures for diagnostic devices and surgical procedures. They will also house 250 new jobs for Costa Ricans in its growth process in the country, who will be involved from the engineering processes to its final production".

In addition, he said, "During 2021, exports of medical equipment increased by 36%, which inspires us to continue working so that more companies like Biomerics find in our country a strategic ally to invest."

Jorge Sequeira, Managing Director of CINDE, commented, "The expansion of Biomerics fills us with pride along with the outstanding performance of the life sciences sector in Costa Rica. As of November 2021, exports of medical devices grew more than 36% compared to the same period in 2020, reaching US$4,786 million. This increase has allowed the country to have greater specialization in the sector, allowing it to participate in the global value chain of medical devices, which ranges from original precision equipment, suppliers, manufacturing contractors, among other services. We look forward to many more years of success and growth for Biomerics Costa Rica.”

For more information on career opportunities at Biomerics, please send your inquiry to

About Biomerics
Founded in 1993, Biomerics is a leading, mid-market medical device contract manufacturer serving the interventional device market. Trusted as a vertically integrated partner with extensive engineering expertise and solutions, Biomerics supplies 20 of the top 30 medical device OEMs. Biomerics provides engineering design & development services, tech transfer manufacturing services, and contract manufacturing services – including sterilization and packaging - for medical devices components, subassemblies, and finished medical devices through eight (8) locations in the United States, Ireland, and Costa Rica – to meet immediate and long-term strategic needs. With its engineering Centers of Excellence, Biomerics is a leader in biocompatible polymers, injection molding, overmolding, extrusion, micro metals machining, medical balloons, catheter assembly, and finished packaging. In addition to operating under a certified ISO 13485:2016 quality system, Biomerics is both FDA registered and compliant with FDA 81 CFR Part 820.